Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Kangen Lebaran masa kecil: Ada ketimpangan di balik nostalgia hari raya

Ilustrasi keluarga sedang memasak untuk menyambut Lebaran.Anom Harya/Shutterstock● Jelang Lebaran, banyak konten di media sosial yang membangkitkan ingatan indahnya Ramadan di masa kecil kita.&#...

Misteri dalam prasasti: Bagaimana perangkat lunak beralgoritma ‘membaca’ batu Singapura

Batu Singapura yang masih menyisakan teka-teki hingga kini.wikipedia.org, CC BY● Perangkat lunak ‘Read-y Grammarian’ menggunakan algoritma komputasi untuk merekonstruksi teks pada ba...

Mengapa ratusan hiu paus terdampar di Selatan Jawa dalam 13 tahun terakhir? Riset kami temukan jawabannya

Penanganan hiu paus terdampar di Purworejo, Senin (8/12/2025)Arief Nugroho/Sealife Indonesia, CC BY-NC● Populasi hiu paus di Indo-Pasifik menurun tajam, diperparah dengan banyaknya kasus hiu pau...